The debate over regulation of generic drugs is far from over. However, the department of pharmaceuticals has decided to revive another long-standing issue regulating the prices of patented drugs, reports CNBC-TV18's Archana Shukla.
first published: Aug 2, 2012 10:00 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live

LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook

Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live

Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
You are already a Moneycontrol Pro user.


